Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5604]

Paclitaxel dosing equally effective in preventing breast cancer progression

Dr Andrew Seidman - Memorial Sloan-Kettering Cancer Center, New York, USA

Paclitaxel dosing equally effective in preventing breast cancer progression ( Dr Andrew Seidman - Memorial Sloan-Kettering Cancer Center, New York, USA )

Paclitaxel chemotherapy schedules equally effective for early-stage breast cancer

Dr G. Thomas Budd - Cleveland Clinic, Cleveland, USA

Paclitaxel chemotherapy schedules equally effective for early-stage breast cancer ( Dr G. Thomas Budd - Cleveland Clinic, Cleveland, USA )

Nintedanib in combination with standard second line therapy in lung cancer

Dr Martin Reck - Hospital Grosshansdorf, Wohrendamm, Germany

Nintedanib in combination with standard second line therapy in lung cancer ( Dr Martin Reck - Hospital Grosshansdorf, Wohrendamm, Germany )

Ganetespib inhibits Hsp90 effective as second-line therapy with docetaxel for advanced lung cancer

Dr Suresh S. Ramalingam - Emory University, Atlanta, USA

Ganetespib inhibits Hsp90 effective as second-line therapy with docetaxel for advanced lung cancer ( Dr Suresh S. Ramalingam - Emory University, Atlanta, USA )

Axillary radiotherapy provides alternative to invasive early stage breast cancer surgery

Dr Emiel J. Rutgers - Netherlands Cancer Institute, Amsterdam

Axillary radiotherapy provides alternative to invasive early stage breast cancer surgery ( Dr Emiel J. Rutgers - Netherlands Cancer Institute, Amsterdam )

Paclitaxel chemotherapy schedules are equally effective for early-stage breast cancer

Dr G. Thomas Budd - MD Cleveland Clinic, USA

Paclitaxel chemotherapy schedules are equally effective for early-stage breast cancer ( Dr G. Thomas Budd - MD Cleveland Clinic, USA )

Selumetinib, the first effective drug for advanced melanoma of the eye

Dr Richard Carvajal - Memorial Sloan Kettering Cancer Center, New York, USA

Selumetinib, the first effective drug for advanced melanoma of the eye ( Dr Richard Carvajal - Memorial Sloan Kettering Cancer Center, New York, USA )

Extended use of tamoxifen reduces breast cancer recurrence and death

Prof Richard Gray - University of Oxford, Oxford, United Kingdom

Extended use of tamoxifen reduces breast cancer recurrence and death ( Prof Richard Gray - University of Oxford, Oxford, United Kingdom )

Ipilimumab and BRAF inhibitors for advanced melanoma

Dr Lynn Schuchter - University of Pennsylvania, USA

Ipilimumab and BRAF inhibitors for advanced melanoma ( Dr Lynn Schuchter - University of Pennsylvania, USA )

Ten years of tamoxifen superior to five in reducing breast cancer recurrence and death

Dr Richard G. Gray - University of Oxford, UK

Ten years of tamoxifen superior to five in reducing breast cancer recurrence and death ( Dr Richard G. Gray - University of Oxford, UK )

Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer

Dr Marcia Brose - Abramson Cancer Center, University of Pennsylvania, USA

Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer ( Dr Marcia Brose - Abramson Cancer Center, University of Pennsylvania, USA )

No survival benefit to adding bevacizumab to standard first-line chemoradiation for glioblastoma

Dr Mark R. Gilbert - University of Texas MD Anderson Cancer Center, Houston, USA

No survival benefit to adding bevacizumab to standard first-line chemoradiation for glioblastoma ( Dr Mark R. Gilbert - University of Texas MD Anderson Cancer Center, Houston, USA )

More from ecancer